The American Journal of Medicine
Volume 121, Issue 1 , Pages 66-71 , January 2008

A Community-Based Evaluation of Sudden Death Associated with Therapeutic Levels of Methadone

References 

  1. Krantz MJ, Mehler PS. Treating opioid dependence (Growing implications for primary care). Arch Intern Med. 2004;164:277–288
  2. Strike CJ, Urbanoski K, Fischer B, et al. Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001. J Addict Dis. 2005;24:39–51
  3. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002;18(4 Suppl):S3–S13
  4. Mercadante S. Methadone in cancer pain. Eur J Pain. 1997;1:77–83discussion 84-85
  5. Lynch ME. A review of the use of methadone for the treatment of chronic noncancer pain. Pain Res Manag. 2005;10:133–144
  6. De Bels D, Staroukine M, Devriendt J. Torsades de pointes due to methadone. Ann Intern Med. 2003;139:E156
  7. Deamer RL, Wilson DR, Clark DS, Prichard JG. Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). J Addict Dis. 2001;20:7–14
  8. Hays H. High dosing methadone and a possible relationship to serious cardia arrhythmias. Pain Res Manag. 2001;6:64
  9. Maremmani I, Pacini M, Cesaroni C, et al. QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res. 2005;11:44–49
  10. Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol. 2005;95:915–918
  11. Mokwe EO, Ositadinma O. Torsade de pointes due to methadone. Ann Intern Med. 2003;139:W64
  12. Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf. 2005;14:747–753
  13. Sala M, Anguera I, Cervantes M. Torsade de pointes due to methadone. Ann Intern Med. 2003;139:W64
  14. Sticherling C, Schaer BA, Ammann P, et al. Methadone-induced torsade de pointes tachycardias. Swiss Med Wkly. 2005;135:282–285
  15. Chugh SS, Jui J, Gunson K, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol. 2004;44:1268–1275
  16. Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation. 2000;102:649–654
  17. Report of a Working Group on Ischaemic Heart Disease Registers. Parts I and II. Copenhagen: Regional Office for Europe WHO; 1969;Euro 5010 1969
  18. McCarthy N, Giesecke J. Case-case comparisons to study causation of common infectious diseases. Int J Epidemiol. 1999;28:764–768
  19. Ehret GB, Voide C, Gex-Fabry M, et al. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med. 2006;166:1280–1287
  20. Fanoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart. 2007;7 Mar Epub.
  21. Kornick CA, Kilborn MJ, Santiago-Palma J, et al. QTc interval prolongation associated with intravenous methadone. Pain. 2003;105:499–506
  22. Krantz MJ, Lewkowiez L, Hays H, et al. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002;137:501–504
  23. Walker PW, Klein D, Kasza L. High dose methadone and ventricular arrhythmias: a report of three cases. Pain. 2003;103:321–324
  24. Kang J, Chen XL, Wang H, Rampe D. Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels. Eur J Pharmacol. 2003;458:25–29
  25. Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 2002;303:688–694
  26. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy. 2003;23:802–805
  27. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol. 2004;43:1625–1629
  28. Teichtahl H, Prodromidis A, Miller B, Cherry G, Kronborg I. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction. 2001;96:395–403
  29. Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26:2007–2012
  30. McCormick GY, White WJ, Zagon IS, Lang CM. Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone. J Pharmacol Exp Ther. 1984;230:353–359
  31. Nielsen S, Taylor DA. The effect of buprenorphine and benzodiazepines on respiration in the rat. Drug Alcohol Depend. 2005;79:95–101
  32. Shen WK, Edwards WD, Hammill SC, et al. Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol. 1995;76:148–152

 Supported in part by NHLBI R01 HL088416 to Sumeet S. Chugh. Sumeet S. Chugh had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. None of the authors have any conflict of interest related to this work. The authors do not have any financial disclosures.

PII: S0002-9343(07)01000-5

doi: 10.1016/j.amjmed.2007.10.009

The American Journal of Medicine
Volume 121, Issue 1 , Pages 66-71 , January 2008

Article Tools